Advertisement

Topics

Elsevier Properties and Elsevier Company Profile

16:21 EDT 22nd April 2018 | BioPortfolio

Elsevier Properties SA is a center of excellence within Reed Elsevier for the management of intellectual property. Elsevier Properties SA owns the PharmaPendium, Beilstein and Reaxys databases. Trademarks including Reaxys(R), PharmaPendium(TM) and The Lancet(R) are owned and protected by Elsevier Properties SA and used under license. For additional information see http://www.reedelsevier.com.


News Articles [307 Associated News Articles listed on BioPortfolio]

Elsevier publishes broad, interdisciplinary reference on cardiovascular research

(Elsevier) Elsevier, the information analytics business specializing in science and health, today announced the publication of the most reputable and easily searchable cardiovascular-focused basic and...

Elsevier adds six start-ups to its pharma innovation hub

Science and health information analytics business Elsevier has finalised the name of six companies that will join its innovation hub...Read More... The post Elsevier adds six start-ups to its pharma i...

Elsevier introduces two major reference works for earth and environmental researchers

(Elsevier) Elsevier, the information analytics business specializing in science and health, today announced the publication of two major reference works for earth and environmental scientists and stud...

Elsevier welcomes six biotech and pharma start-ups to The Hive

Start-ups working on a range of technologies and discoveries — from AI to immunotherapy — receive complimentary access to Elsevier's information solutions to accelerate innovation

Scientific research on disasters represents 0.22 percent of global scholarly output, shows Elsevier report

(Elsevier) Despite loss of life and economic devastation worldwide due to increasingly frequent natural and man-made disasters, scientific research on disasters represents a small percentage of schola...

Elsevier Welcomes Six Biotech and Pharma Start-ups to The Hive, Supporting the Most Cutting-edge Research in Industry

Start-ups working on a range of technologies and discoveries - from AI to immunotherapy - receive complimentary access to Elsevier's information solutions to accelerate innovation

Elsevier launches Mendeley Data

Elsevier, the information analytics business specializing in science and health, has launched Mendeley Data, a new, cloud-based platform designed to help universities and researchers manage, share and...

Researchers gain greater insights into experimental data by leveraging the growing collections of molecular interactions from published literature

SolveBio and Elsevier, the information analytics company, have announced a collaboration to integrate the use of Pathway Studio, Elsevier’s database of biological molecular interactions and curated ...

PubMed Articles [891 Associated PubMed Articles listed on BioPortfolio]

Removal notice to "A "cough induced" pelvic fracture as the first sign of a malignant neoplasm" IJSCR Volume 11 (2015) 75-77.

This article has been removed: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been removed at the request ...

TEMPORARY REMOVAL: Rapid screening of abused drugs by direct analysis in real time (DART) coupled to time-of-flight mass spectrometry (TOF-MS) combined with ion mobility spectrometry (IMS).

The publisher regrets that this article has been temporarily removed. A replacement will appear as soon as possible in which the reason for the removal of the article will be specified, or the article...

Hundreds of German universities set to lose access to Elsevier journals.

Elsevier's approach to the bioCADDIE 2016 Dataset Retrieval Challenge.

https://data.mendeley.com/datasets/zd9dxpyybg/1.

RETRACTED: The revised stratigraphy of the hominin-bearing site of Kromdraai (Gauteng, South Africa) and associated perspectives.

This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). This article has been retracted at the request of the co-Editors-in...

Clinical Trials [848 Associated Clinical Trials listed on BioPortfolio]

Metabolic Viral Host Properties

Patients' metabolic properties may affect their immune response. This study aims to assess the effect of hosts' metabolic properties to viral infection.

Measurement of Mechanical Properties of the Healing Achilles Tendon With or Without Early Weightbearing

The purpose of this study is to measure the mechanical properties of healing Achilles tendons in humans after early controlled weightbearing, compared with a control group in a randomized,...

Measuring the Electrical Properties of Malignant Tissues Ex Vivo

Previously published studies have indicated that there exist difference in electrical properties (EPs), i.e., the conductivity and relative permittivity, between malignant and adjacent nor...

Measuring the Electrical Properties of Malignant Tissues In Vivo

Previously published studies have indicated that there exist difference in electrical properties (EPs), i.e., the conductivity and relative permittivity, between malignant and adjacent nor...

Observational Study of Thrombogenic Properties in 220 Patients With Proximal Femur Fracture

Measurement of thrombogenic properties by TEG and MEA and observation of thrombotic events over 2 years in 220 patients with hip fracture.

Companies [375 Associated Companies listed on BioPortfolio]

Elsevier Properties SA and Elsevier

Elsevier Properties SA is a center of excellence within Reed Elsevier for the management of intellectual property. Elsevier Properties SA owns the PharmaPendium, and Reaxys databases. Trademarks i...

Elsevier and Elsevier Properties SA

Elsevier Properties SA is a center of excellence within Reed Elsevier for the management of intellectual property. Elsevier Properties SA owns the PharmaPendium(TM), Beilstein and Reaxys databases...

Elsevier Properties and Elsevier

Elsevier Properties SA is a center of excellence within Reed Elsevier for the management of intellectual property. Elsevier Properties SA owns the PharmaPendium, Beilstein and Reaxys databases. Tr...

Reed Elsevier Group

Reed Elsevier is a world leading publisher of information and solutions for professional users operating in four core markets: Science & MedicalLegalEducationBusinessIn February 2006, Reed Elsevier re...

Elsevier and Gold Standard Elsevier

Based in Tampa, FL, Gold Standard/Elsevier uses innovative technologies to provide a complete suite of drug information and decision support solutions. With a tenacious commitment to product quali...

More Information about "Elsevier Properties and Elsevier" on BioPortfolio

We have published hundreds of Elsevier Properties and Elsevier news stories on BioPortfolio along with dozens of Elsevier Properties and Elsevier Clinical Trials and PubMed Articles about Elsevier Properties and Elsevier for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Elsevier Properties and Elsevier Companies in our database. You can also find out about relevant Elsevier Properties and Elsevier Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record